Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction

Journal of the American College of Cardiology

Volumn 22, Issue 4 SUPPL. 1, 1993, Pages

  Pouleur, Hubert G ^a   Konstam, Marvin A ^b   Udelson, James E ^b   Rousseau, Michel F ^a   The SOLVD Investigators, ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; ENALAPRIL; VASODILATOR AGENT;

ADULT; AGED; CINEANGIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART STRESS; HEART VENTRICLE WALL; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIANGIOGRAPHY; THICKNESS;

ADULT; AGED; BELGIUM; CANADA; ENALAPRIL; FEMALE; GATED BLOOD-POOL IMAGING; HEART; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART VENTRICLE; HUMAN; MALE; MIDDLE AGE; STROKE VOLUME; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 0027360571     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(93)90462-A     Document Type: Article

References (23)

1. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications
2. Left ventricular remodeling after myocardial infarction: progression toward heart failure
3. Mechanisms leading to the development of heart failure in pressure-overload hypertrophy
4. Immediate and delayed mechanisms of cardiac adaptation to a haemodynamic overload
5. Influence of chronic captopril therapy on the infarcted left ventricle of the rat
6. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
7. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion
8. Long-term effects of xamoterol on left ventricular fonction and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease
9. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure
10. Studies of Left Ventricular Dysfunction (SOLVD)—rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
11. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
12. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
13. Effect of acute angiotensin converting enzyme inhibition on left ventricular filling in patients with congestive heart failure: relation to right ventricular volumes
14. Effects of benazeprilat on left ventricular systolic and diastolic function and neuro-humoral status in patients with ischemic heart disease
15. Digital angiography: an open-system dedicated to left ventricular function studies
16. Impaired early left ventricular relaxation in coronary artery disease: effects of intracoronary nifedipine
17. Algorithms for wall motion analysis: importance of data smoothing and correct determination of end-systole
18. Elastic properties of the myocardium: a quantitative approach with physiological and clinical applications
19. Long-term effects of enalapril on left ventricular dilatation in asymptomatic patients with reduced ejection fraction: comparison with symptomatic patients (abstr)
20. Cardiac mechanics during development of heart failure
21. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
22. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
23. Effects of long-term enalapril therapy on echocardiographic variables in SOLVD patients (abstr)